Literature DB >> 19429987

Expression of connexins in normal and neoplastic canine bone tissue.

D S Sanches1, C G Pires, H Fukumasu, B Cogliati, P Matsuzaki, L M Chaible, L N Torres, C R A Ferrigno, M L Z Dagli.   

Abstract

Previous studies showed that intercellular communication by gap junctions has a role in bone formation. The main connexin involved in the development, differentiation, and regulation of bone tissue is connexin (Cx) 43. In addition, Cx46 is also expressed, mostly localized within the trans-Golgi region. Alterations in the expression pattern and aberrant location of these connexins are associated with oncogenesis, demonstrating a deficient gap junctional intercellular communication (GJIC) capacity in neoplastic tissues. In this study, we evaluated normal and neoplastic bone tissues regarding the expression of Cx43 and Cx46 by immunofluorescence, gene expression of these connexins by real-time PCR, and their correlation with cell proliferation index and deposition of collagen. Fourteen neoplastic bone lesions, including 13 osteosarcomas and 1 multilobular tumor of bone, were studied. The mRNA levels of Cx43 were similar between normal and neoplastic bone tissue. In normal bone tissue, the Cx43 protein was found mainly in the intercellular membranes. However, in all bone tumors studied here, the Cx43 was present in both cell membranes and also aberrantly in the cytoplasm. Regarding only tumor samples, we determined a possible inverse correlation between Cx43 expression and cellular proliferation, although a positive correlation between Cx43 expression and collagen deposition was also noted. In contrast, Cx46 had lower levels of expression in neoplastic bone tissues when compared with normal bone and was found retained in the perinuclear region. Even though there are differences between these two connexins regarding expression in neoplastic versus normal tissues, we concluded that there are differences regarding the subcellular location of these connexins in normal and neoplastic dog bone tissues and suggest a possible correlation between these findings and some aspects of cellular proliferation and possibly differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429987     DOI: 10.1354/vp.08-VP-0263-S-FL

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  11 in total

1.  Cell proliferation and expression of connexins differ in melanotic and amelanotic canine oral melanomas.

Authors:  Tarso Felipe Teixeira; Luciana Boffoni Gentile; Tereza Cristina da Silva; Gregory Mennecier; Lucas Martins Chaible; Bruno Cogliati; Marco Antonio Leon Roman; Marco Antonio Gioso; Maria Lucia Zaidan Dagli
Journal:  Vet Res Commun       Date:  2013-10-15       Impact factor: 2.459

2.  Altered expression and localization of connexin32 in human and murine gastric carcinogenesis.

Authors:  Hyang Jee; Ki Taek Nam; Hyo-Jung Kwon; Sang-Uk Han; Dae-Yong Kim
Journal:  Dig Dis Sci       Date:  2010-11-17       Impact factor: 3.199

3.  Complementary expression and phosphorylation of Cx46 and Cx50 during development and following gene deletion in mouse and in normal and orchitic mink testes.

Authors:  R-Marc Pelletier; Casimir D Akpovi; Li Chen; Nalin M Kumar; María L Vitale
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-05-27       Impact factor: 3.619

4.  The role of Connexin 46 promoter in lens and other hypoxic tissues.

Authors:  Samuel A Molina; Dolores J Takemoto
Journal:  Commun Integr Biol       Date:  2012-03-01

5.  Up-regulation of BMP2/4 signaling increases both osteoblast-specific marker expression and bone marrow adipogenesis in Gja1Jrt/+ stromal cell cultures.

Authors:  Tanya Zappitelli; Frieda Chen; Jane E Aubin
Journal:  Mol Biol Cell       Date:  2015-01-07       Impact factor: 4.138

6.  Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways.

Authors:  Bixing Zhao; Wenxiu Zhao; Yu Wang; Yaping Xu; Jianfeng Xu; Kai Tang; Sheng Zhang; Zhenyu Yin; Qiao Wu; Xiaomin Wang
Journal:  Oncotarget       Date:  2015-04-30

7.  Distinctive actions of connexin 46 and connexin 50 in anterior pituitary folliculostellate cells.

Authors:  María Leiza Vitale; Christopher J Garcia; Casimir D Akpovi; R-Marc Pelletier
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

8.  Effects of Alpha-Connexin Carboxyl-Terminal Peptide (aCT1) and Bowman-Birk Protease Inhibitor (BBI) on Canine Oral Mucosal Melanoma (OMM) Cells.

Authors:  Ayami Sato; Ivone Izabel Mackowiak da Fonseca; Márcia Kazumi Nagamine; Gabriela Fernandes de Toledo; Rennan Olio; Francisco Javier Hernandez-Blazquez; Tomohiro Yano; Elizabeth Shinmay Yeh; Maria Lucia Zaidan Dagli
Journal:  Front Vet Sci       Date:  2021-06-10

9.  Higher incidence of lung adenocarcinomas induced by DMBA in connexin 43 heterozygous knockout mice.

Authors:  Krishna Duro de Oliveira; Marcello Vannucci Tedardi; Bruno Cogliati; Maria Lúcia Zaidan Dagli
Journal:  Biomed Res Int       Date:  2013-10-03       Impact factor: 3.411

10.  Connexin32 inhibits gastric carcinogenesis through cell cycle arrest and altered expression of p21Cip1 and p27Kip1.

Authors:  Hyang Jee; Su-Hyung Lee; Jun-Won Park; Bo-Ram Lee; Ki-Taek Nam; Dae-Yong Kim
Journal:  BMB Rep       Date:  2013-01       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.